The company’s net profit at Rs ₹555 crore for the quarter under review was down 55 per cent from Rs ₹1,222 crore in the same period last year For the full story, visit the source.
Business
Cipla looks to ensure consistent drug supplies, as costs increase due to West Asia war, says MD & Global CEO
The company’s net profit at Rs ₹555 crore for the quarter under review was down 55 per cent from Rs ₹1,222 crore in the same period last year
By BL Mumbai Bureau· BusinessLine· 1 day ago· 2 min read
This summary is sourced from BusinessLine. Read the full article at:BusinessLine